About This BlogThe SW Health Law Checkup is written by the attorneys of Snell & Wilmer to provide their insight on an array of regulatory and compliance matters related to federal and state fraud and abuse laws and regulations, reimbursement, credentialing and employment of providers, joint ventures and physician-entity integration, best practices in compensation and contracting, value-based purchasing and contracting with providers.
SAMHSA Issues Final Rule Modernizing Confidentiality Requirements for Patients Receiving Substance Use Disorder Treatment
Last month, the U.S. Department of Health and Human Services (“HHS”) Substance Abuse and Mental Health Services Administration (“SAMHSA”) released a Final Rule updating the Confidentiality of Alcohol and Drug Abuse Patient Records regulations at Title 42 of the Code of Federal Regulations Part 2 (“Part 2”). The Final Rule serves to modernize the regulations to facilitate information exchange and health integration while protecting the privacy of patients seeking treatment for substance use and the confidentiality of their medical records. The Part 2 regulations were promulgated in 1975 to protect the identities of individuals seeking substance use treatment from possible negative social consequences and stigma that could deter individuals from seeking treatment. They have not been substantively updated since 1987. The Final Rule was intended to go into effect February 17, 2017; however a Trump administration memorandum issued in mid-January establishing a “regulatory freeze” has delayed the effective date for at least sixty days from the date of the memorandum. In response to this directive, SAMHSA has postponed the Final Rule’s effective date to March 21, 2017. The updates to the Part 2 Regulations seek to enable improvements in healthcare … Continue reading
Share this Article: